Park Avenue Securities LLC Exelixis, Inc. Transaction History

Park Avenue Securities LLC

  • $8.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023
SELL
$14.96 - $17.39 $16,874 - $19,615
-1,128 Reduced 8.88%
11,570 $0
Q3 2022

Nov 01, 2022
SELL
$15.68 - $22.27 $46,789 - $66,453
-2,984 Reduced 19.03%
12,698 $199,000
Q2 2022

Jul 27, 2022
BUY
$17.44 - $23.16 $44,594 - $59,220
2,557 Added 19.48%
15,682 $326,000
Q1 2022

Apr 29, 2022
BUY
$17.03 - $22.67 $223,518 - $297,543
13,125 New
13,125 $298,000

Others Institutions Holding EXEL

# of Institutions
503
Shares Held
244M
Call Options Held
2.54M
Put Options Held
2.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.6B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Park Avenue Securities LLC Portfolio

Follow Park Avenue Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email